Abstract:In the last few years, next-generation sequencing (NGS)5 has revolutionized the approaches by which we interrogate the genetic causes of rare single-gene disorders (1). More recently, NGS has been rapidly moving into the clinical diagnostics arena and transforming the practice of molecular diagnostics testing. Many NGS-based tests for multigene panels are available in clinical laboratories. Now, proof-of-principle studies are demonstrating the feasibility of using exome sequencing for clinical testing (2–4). Dixon-Salazar et al. used exome sequencing to interrogate a cohort of 118 probands with recessive neurodevelopmental disorders and identified disease-causing mutations in 19% of the probands. Importantly, exome sequencing uncovered mutations in 10 probands (8% of the cohort) that altered the initial clinical diagnosis and led in some cases to a change in patient management (2). Calvo et al. tested 42 infants with mitochondrial diseases with the “MitoExome” (mitochondrial DNA plus exons of approximately 1000 nuclear genes) and confirmed that 10 patients (24% of the cohort) had pathogenic mutations. In addition, these investigators identified 2 novel disease-causing genes (3). Need et al. used exome sequencing in family trios to investigate patients with a broad range of phenotypic presentations and reported a 33% diagnostic yield: 4 of 12 patients with apparently causal mutations and 2 additional potentially novel disease-causing genes (4). Although the number of patients tested thus far by whole-exome sequencing (WES) or whole-genome sequencing (WGS) is still small, the data reported in these recent studies have defined the minimal diagnostic yields of such NGS-based clinical tests at their early stage of implementation, thus demonstrating the practicality of NGS-based tests. We anticipate that the clinical utility of NGS-based tests will improve further in the next few years and that more patients will benefit from improved diagnostic accuracy and more-appropriate treatment. Conventional molecular diagnostics tests evaluate a defined …

Enhancing Clinical Applications by Evaluation of Sensitivity and Specificity in Whole Exome Sequencing

Clinical application of whole-exome sequencing across clinical indications

Comparison of medical management and genetic counseling options pre- and post-whole exome sequencing for patients with positive and negative results.

Comprehensive Outline of Whole Exome Sequencing Data Analysis Tools Available in Clinical Oncology

A review of consensus statements, practice resources, standards and guidelines for clinical applications of next-generation sequencing technologies in the United States

Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilities

Evaluation of Somatic Copy Number Estimation Tools for Whole-Exome Sequencing Data

Using Off-Target Data from Whole-Exome Sequencing to Improve Genotyping Accuracy, Association Analysis and Polygenic Risk Prediction.

The usefulness of whole-exome sequencing in routine clinical practice

Exome and Whole-Genome Sequencing As Clinical Tests: a Transformative Practice in Molecular Diagnostics.

Evaluation of three read-depth based CNV detection tools using whole-exome sequencing data

Benchmarking of Germline Copy Number Variant Callers from Whole Genome Sequencing Data for Clinical Applications

Enhancing Variant Calling in Whole-Exome Sequencing Data Using Population-Matched Reference Genomes.

Enhancing Variant Calling in Whole Exome Sequencing (WES) Data Using Population-Matched Reference Genomes

Promises, pitfalls and practicalities of prenatal whole exome sequencing

EXaCT-2: An augmented and customizable oncology-focused whole exome sequencing platform

Systematic dissection of biases in whole-exome and whole-genome sequencing reveals major determinants of coding sequence coverage

Development and Validation of a Whole-Exome Sequencing Test for Simultaneous Detection of Point Mutations, Indels and Copy-Number Alterations for Precision Cancer Care

An evaluation of copy number variation detection tools from whole-exome sequencing data.

Variant calling pipelines for whole exome sequencing in clinical context

A cost-effective sequencing method for genetic studies combining high-depth whole exome and low-depth whole genome